AG-120 in People With IDH1 Mutant Chondrosarcoma
AG-120 in People With IDH1 Mutant Chondrosarcoma
Active, not recruiting · NCT04278781 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AG-120 in People With IDH1 Mutant Chondrosarcoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, chondrosarcoma, connective tissue neoplasm, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2026-04-23 | NCT04278781 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 18 |
| Memorial Sloan Kettering Cancer Center | 753 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University (Specimen Analysis Only) | New York | United States | 1 |
| Johns Hopkins Hospital (Data Collection Only) | Baltimore | United States | 2 |
| MD Anderson Cancer Center (Data Collection Only) | Houston | United States | 9 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| The Ohio State University (Data Collection Only) | Columbus | United States | 1 |